SWVL vs. SLNO
SWVL (Swvl Holdings Corp) and SLNO (Soleno Therapeutics, Inc.) are both stocks. SWVL operates in Software - Application (Technology), while SLNO operates in Biotechnology (Healthcare). Over the past 3 years, SWVL returned 8.74%/yr vs 122.08%/yr for SLNO. At a 0.04 correlation, their price movements are largely independent.
Performance
SWVL vs. SLNO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SWVL achieves a -19.47% return, which is significantly lower than SLNO's 14.49% return.
SWVL
- 1D
- -3.16%
- 1M
- -21.54%
- YTD
- -19.47%
- 6M
- -41.15%
- 1Y
- -68.32%
- 3Y*
- 8.74%
- 5Y*
- —
- 10Y*
- —
SLNO
- 1D
- 0.00%
- 1M
- 0.26%
- YTD
- 14.49%
- 6M
- 10.17%
- 1Y
- -29.94%
- 3Y*
- 122.08%
- 5Y*
- 28.47%
- 10Y*
- -5.77%
SWVL vs. SLNO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
SWVL Swvl Holdings Corp | -19.47% | -70.23% | 281.39% | -51.14% | -98.54% |
SLNO Soleno Therapeutics, Inc. | 14.49% | 3.00% | 11.68% | 1,932.83% | -40.81% |
Correlation
The correlation between SWVL and SLNO is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Apr 1, 2022 | 0.04 |
Fundamentals
SWVL:
$16.53M
SLNO:
$2.81B
SWVL:
-$0.49
SLNO:
$1.81
SWVL:
0.91
SLNO:
9.90
SWVL:
4.50
SLNO:
5.67
SWVL:
$18.26M
SLNO:
$285.01M
SWVL:
$3.93M
SLNO:
$187.70M
SWVL:
-$3.28M
SLNO:
$101.57M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SWVL vs. SLNO — Risk / Return Rank
SWVL
SLNO
SWVL vs. SLNO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Swvl Holdings Corp (SWVL) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SWVL | SLNO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.90 | -0.43 | -0.47 |
Sortino ratioReturn per unit of downside risk | -1.59 | -0.26 | -1.33 |
Omega ratioGain probability vs. loss probability | 0.82 | 0.96 | -0.14 |
Calmar ratioReturn relative to maximum drawdown | -0.94 | -0.44 | -0.50 |
Martin ratioReturn relative to average drawdown | -1.42 | -0.76 | -0.66 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SWVL | SLNO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.90 | -0.43 | -0.47 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.12 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.03 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.50 | -0.07 | -0.43 |
Drawdowns
SWVL vs. SLNO - Drawdown Comparison
The maximum SWVL drawdown since its inception was -99.72%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for SWVL and SLNO.
Loading charts...
Drawdown Indicators
| SWVL | SLNO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.72% | -99.86% | +0.14% |
Max Drawdown (1Y)Largest decline over 1 year | -72.44% | -66.04% | -6.40% |
Max Drawdown (3Y)Largest decline over 3 years | -92.32% | -66.04% | -26.28% |
Max Drawdown (5Y)Largest decline over 5 years | — | -94.96% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.06% | — |
Current DrawdownCurrent decline from peak | -99.39% | -91.92% | -7.47% |
Average DrawdownAverage peak-to-trough decline | -93.70% | -90.59% | -3.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 48.36% | 38.58% | +9.78% |
Volatility
SWVL vs. SLNO - Volatility Comparison
Swvl Holdings Corp (SWVL) has a higher volatility of 21.01% compared to Soleno Therapeutics, Inc. (SLNO) at 0.32%. This indicates that SWVL's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SWVL | SLNO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.01% | 0.32% | +20.69% |
Volatility (6M)Calculated over the trailing 6-month period | 63.66% | 44.82% | +18.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.89% | 69.01% | +6.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 139.96% | 243.64% | -103.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 139.96% | 185.28% | -45.32% |
Dividends
SWVL vs. SLNO - Dividend Comparison
Neither SWVL nor SLNO has paid dividends to shareholders.
Financials
SWVL vs. SLNO - Financials Comparison
This section allows you to compare key financial metrics between Swvl Holdings Corp and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SWVL vs. SLNO - Profitability Comparison
SWVL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Swvl Holdings Corp reported a gross profit of 1.21M and revenue of 5.28M. Therefore, the gross margin over that period was 22.9%.
SLNO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Soleno Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 94.60M. Therefore, the gross margin over that period was 0.0%.
SWVL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Swvl Holdings Corp reported an operating income of -128.35K and revenue of 5.28M, resulting in an operating margin of -2.4%.
SLNO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Soleno Therapeutics, Inc. reported an operating income of 31.28M and revenue of 94.60M, resulting in an operating margin of 33.1%.
SWVL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Swvl Holdings Corp reported a net income of -340.62K and revenue of 5.28M, resulting in a net margin of -6.5%.
SLNO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Soleno Therapeutics, Inc. reported a net income of 31.38M and revenue of 94.60M, resulting in a net margin of 33.2%.
Frequently Asked Questions
SWVL and SLNO have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SWVL has higher volatility (21.01%) compared to SLNO (0.32%). In terms of maximum drawdown, SWVL dropped -99.72% vs SLNO's -99.86%.
SLNO currently has the higher Sharpe Ratio (-0.43 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SWVL and SLNO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer